Hayim Raclaw
Directeur Général chez PsyTech Global
Profil
Hayim Raclaw is currently the Chief Executive Officer and Director at PsyTech Global since 2020.
Prior to this, he worked as the Chief Operating Officer at Wesana Health Holdings, Inc.
Postes actifs de Hayim Raclaw
| Sociétés | Poste | Début |
|---|---|---|
PsyTech Global
 PsyTech Global Packaged SoftwareTechnology Services PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020. | Directeur Général | 01/02/2020 |
Anciens postes connus de Hayim Raclaw
| Sociétés | Poste | Fin |
|---|---|---|
| WESANA HEALTH HOLDINGS INC. | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| WESANA HEALTH HOLDINGS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
PsyTech Global
PsyTech Global Packaged SoftwareTechnology Services PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020. | Technology Services |
